- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Bisphosphonate Use Linked to Decreased Breast Cancer Risk
The use of bisphosphonates, which are commonly taken to prevent and treat osteoporosis, may lower the risk of breast cancer, according to the results of a recent study led by Polly A. Newcomb, PhD, MPH, a researcher at the Fred Hutchinson Cancer Research Center in Seattle.
The use of bisphosphonates, which are commonly taken to prevent and treat osteoporosis, may lower the risk of breast cancer, according to the results of a recent study led by Polly A. Newcomb, PhD, MPH, a researcher at the Fred Hutchinson Cancer Research Center in Seattle.1
In this population-based case-control study, 2936 patients with invasive breast cancer and 2975 without cancer were included from 2003 to 2006. All participants were younger than 70 years and were treated in Wisconsin. Participant use of bisphosphonates was identified during interviews.
An increasing duration of bisphosphonate use was shown to be associated with an increased risk reduction. The authors noted that this risk reduction was seen in women who were not obese. According to the study authors, nitrogen-containing bisphosphonate compounds, which are commonly used to treat patients with osteoporosis, may show antitumor properties by inhibiting protein prenylation.
References:
Reference
1. Newcomb PA, Trentham-Dietz A, Hampton JM. Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk. Br J Cancer. 2010 Feb 16; [Epub ahead of print].
Primary Viewpoints Episode 7: Antidepressants for Back Pain, Osteoarthritis Pain
February 25th 2021Listen to our newest podcast episode where the lead author of a recent meta-analysis shares his findings on the safety and efficacy of antidepressant medications to treat back and osteoarthritis pain.
Podcast: Arthritis, Anxiety, and Depression: Managing a Common Comorbidity
May 14th 2012Anxiety is even more common than depression among people who have arthritis, a new study has shown. Here to discuss the implications for diagnosis and treatment is Eilzabeth Lin MD, a family medicine physician who is a longstanding researcher in the field of depression and pain.
